Pharmaceutical Industry-led initiative of the Year

This award was open to any pharmaceutical, life science, diagnostics and devices company. It aims to recognise outstanding contribution to diabetes care by the life sciences industry, beyond that of traditional medicines or devices supply.



HypoBox by BBI Healthcare

Pharmaceutical Industry-led initiative of the Year

This initiative was started in response to the need for a 'one-stop' hypoglycaemia management first aid box. This developed into a package providing education training and support to ward staff on hypoglycaemia management in line with national and local guidance. Successful implementation of the initiative ensures that hypoglycaemia is treated effectively and consistently across all wards, improving staff training, patient outcomes and experience as well as reducing bed stays and overall cost.

Second place

Excellence in Diabetes Programme by Sanofi

Through market research, sanofi-aventis discovered that Diabetes Specialist Nurses (DSN) felt they could benefit from some 'softer' skills training in areas such as leadership, effective communication with patients and peers, and personal development. The ‘Excellence in Diabetes' (EID) programme was created, together with an expert faculty, as a unique, tailored learning tool to provide fresh and innovative, 'soft' skills to DSNs. Complemented by a constantly evolving website and several workshops, the programme enables DSNs to achieve their personal potential and improve patient outcomes.


Back to QiC Diabetes Results

Quality In Care Diabetes

QiC Diabetes is partnered by:
Supported by:
  • 2023 KEY DATES
  • Open for Entry:
    Thursday 27 April 2023
  • Entry Deadline:
    Friday 7 July 2023
  • Judging Day:
    Tuesday 8 September 2023
  • Awards Ceremony:
    Thursday 12 October 2023